| 2025 |
Hughes, G. A., Inacio, M. C., Rowett, D., Caughey, G. E., Air, T., Lang, C., . . . Sluggett, J. K. (2025). Prolonged Use of Antidepressants Among Older People Residing in Long-Term Care Facilities. Journal of the American Medical Directors Association (JAMDA): long-term care: management, applied research and clinical issues, 26(4), 105482-1-105482-7.
DOI Scopus2 WoS2 Europe PMC1 |
| 2025 |
Hughes, G. A., Inacio, M. C., Rowett, D., Caughey, G. E., Air, T., Lang, C., . . . Sluggett, J. K. (2025). Risk of adverse outcomes associated with mirtazapine compared to sertraline use among older people living in long-term care facilities. Age and Ageing, 54(4, article no. afaf074), 1-12.
DOI Scopus4 WoS3 Europe PMC3 |
| 2025 |
Sukkar, M. B., Ainley, R., Barrett, C., Bond, S., Bradbury, L. A., Briggs, A. M., . . . Hill, C. L. (2025). Development of the Australian Rheumatology Association Clinical Care Standard for the diagnosis and management of rheumatoid arthritis in adults. Journal of Rheumatology, 52(9), 883-892.
DOI |
| 2025 |
Babu, D., Luetsch, K., Kalisch Ellett, L., Harmon, J., Marotti, S., Wisdom, A., & Rowett, D. (2025). Realist review of pharmacists' integration and participation in interprofessional ward rounds: what works, for whom, why and in what circumstances.. Research in Social and Administrative Pharmacy, 21(11), 831-841.
DOI |
| 2025 |
Mekuria, A. B., Tegegn, H. G., Andrade, A. Q., Lim, R., Rowett, D., & Roughead, E. E. (2025). Patient reported tools for assessing potential medicine-related symptoms: a systematic review. Research in Social and Administrative Pharmacy, 21(4), 193-204.
DOI |
| 2025 |
Hughes, G. A., Inacio, M. C., Rowett, D., Lang, C., Jorissen, R. N., Corlis, M., & Sluggett, J. K. (2025). Setting of initiation and factors associated with antidepressant use on entry to long-term care facilities. British Journal of Clinical Pharmacology, 91(6), 1749-1759.
DOI |
| 2025 |
Mekuria, A. B., Lim, R., Andrade, A. Q., Rowett, D., Boord, M. S., Hedstroem, M., . . . Roughead, E. E. (2025). Tool for longitudinal monitoring of medicine-related symptoms in older people: a feasibility study. Journal of Pharmacy Practice and Research, 1-11.
DOI Scopus1 |
| 2025 |
Mekuria, A. B., Andrade, A. Q., Lim, R., Rowett, D., Hedstrom, M., & Roughead, E. E. (2025). Responsiveness and minimum important change of the Pharmacotherapeutic Symptom Evaluation-20-Australian version: a tool for measuring changes in medicine-related symptoms over time. International Journal Of Clinical Pharmacy, online, 1-12.
DOI |
| 2025 |
Mekuria, A. B., Lim, R., Andrade, A. Q., Rowett, D., & Roughead, E. E. (2025). Detection of Adverse Medicine Events by Pharmacists in Residential Aged Care Facilities: secondary Analysis of Data From ReMInDAR Trial. Pharmacoepidemiology And Drug Safety, 34(11, article no. e70261), 1-9.
DOI |
| 2025 |
Halimi, S. N., Rowett, D., & Luetsch, K. (2025). A realist review of programs fostering the resilience of healthcare students: What works, for whom and why?. Research in Social and Administrative Pharmacy, 21(1), 22-31.
DOI |
| 2025 |
Al-Diery, T., Marotti, S., Lee, K. M. K., Bishawi, A. H., Rowett, D., & Johnson, J. L. (2025). Unlocking Findings of Entrustable Professional Activities for Trainee Development, Entrustment, and Practice Readiness in Pre-registration Pharmacy Training: A Systematic Review. American Journal of Pharmaceutical Education, 89(9), 22 pages.
DOI |
| 2025 |
Al-Diery, T., Marotti, S., Sim, Y. T., Rowett, D., & Johnson, J. L. (2025). Entrustment in Action: Factors that Contribute to Entrustment Decision-Making Through the Lens of the Supervisor and the Intern. American Journal of Pharmaceutical Education, 89(9), 8 pages.
DOI Scopus1 WoS1 Europe PMC1 |
| 2025 |
Al-Diery, T., Marotti, S., Rowett, D., & Johnson, J. L. (2025). Entrusting Pharmacy Trainees: Exploring Expectations of Entrustment Across the Pharmacy Intern Year in Australia. American Journal of Pharmaceutical Education, 89(8), 8 pages.
DOI Scopus1 WoS1 Europe PMC1 |
| 2024 |
Halimi, S. N., Mirzaei, A., Rowett, D., & Luetsch, K. (2024). An investigation of academic resilience, resilience, and empathy in pharmacy students: implications for pharmacy education. Pharmacy Education, 24(1), 226-237.
DOI |
| 2024 |
Lee, K. M., Koeper, I., Johnson, M., Page, A., Rowett, D., & Johnson, J. (2024). Multidisciplinary perspectives on roles of hospital pharmacists in tertiary settings: a qualitative study. International Journal for Quality in Health Care, 36(1), 1-9.
DOI Scopus10 Europe PMC8 |
| 2024 |
Drake, R., Prael, G., Phyo, Y., Chang, S., Hunt, J., Herbert, A., . . . Currow, D. (2024). Gabapentin for pain in pediatric palliative care. Journal of Pain and Symptom Management, 67(3), 212-222.
DOI |
| 2024 |
Hughes, G. A., Inacio, M. C., Rowett, D., Lang, C., Jorissen, R. N., Corlis, M., & Sluggett, J. K. (2024). National trends in antidepressant use in Australian residential aged care facilities (2006-2019). Journal of the American Medical Directors Association, 25(6, article no. 104957), 1-13.
DOI |
| 2024 |
Luetsch, K., Wong, G., & Rowett, D. (2024). A realist synthesis of educational outreach visiting and integrated academic detailing to influence prescribing in ambulatory care: why relationships and dialogue matter. BMJ Quality & Safety, 33(1), 43-54.
DOI |
| 2024 |
Babu, D., Marotti, S., Rowett, D., Lim, R., Wisdom, A., & Kalisch Ellett, L. (2024). What is impacting clinical pharmacists' participation in an interprofessional ward round: a thematic analysis of a national survey. Journal of Interprofessional Care, 38(3), 444-452.
DOI Scopus4 WoS5 Europe PMC1 |
| 2024 |
Al Naji, H., Inglis, J. M., Tucker, E., Rowett, D., Larcombe, R., Medlin, S., . . . Thynne, T. (2024). Prescribing of antivirals for COVID-19 in a South Australian local health network according to statewide guidelines. Internal Medicine Journal, 54(1), 183-186.
DOI Scopus1 Europe PMC1 |
| 2024 |
Babu, D., Rowett, D., Kalisch Ellett, L., Marotti, S., Wisdom, A., Lim, R., & Harmon, J. (2024). Exploration of 'micro' level factors that affect the involvement of clinical pharmacists in interprofessional ward rounds in hospitals: through the lens of social cognitive theory. Research in Social and Administrative Pharmacy, 20(7), 654-664.
DOI Scopus4 WoS3 Europe PMC3 |
| 2024 |
Hoon, E., Edwards, J., Robinson, P., Rowett, D., Stocks, N., Keen, H. I., & Hill, C. L. (2024). How is gout currently managed, and is there interest in changing the way we deliver care? A qualitative exploratory study. Australian Journal of General Practice, 53(11), 864-871.
DOI |
| 2023 |
Lyon, A., Quinlivan, A., Lester, S., Barrett, C., Whittle, S. L., Rowett, D., . . . Hill, C. L. (2023). Vaccination Rates, Perceptions, and Information Sources Used by People With Inflammatory Arthritis. ACR Open Rheumatology, 5(2), 1-9.
DOI Scopus7 WoS5 Europe PMC5 |
| 2023 |
Babu, D., Rowett, D., Lim, R., Marotti, S., Wisdom, A., & Kalisch Ellett, L. (2023). Clinical pharmacists' participation in ward rounds in hospitals: responses from a national survey. International Journal Of Pharmacy Practice, 31(4), 409-416.
DOI Scopus7 WoS8 Europe PMC5 |
| 2023 |
Kalisch Ellett, L. M., Dorj, G., Andrade, A. Q., Bilton, R. L., Rowett, D., Whitehouse, J., . . . Roughead, E. E. (2023). Prevalence and preventability of adverse medicine events in a sample of Australian aged-care residents: a secondary analysis of data from the ReMInDAR trial. Drug Safety, 46(5), 493-500.
DOI Scopus4 WoS3 Europe PMC3 |
| 2023 |
Dorj, G., Nair, N. P., Bereznicki, L., Kelly, T. L., Pratt, N., Kalisch-Ellett, L., . . . Roughead, E. (2023). Correction to: Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial (Drugs & Aging, (2023), 40, 1, (49-58), 10.1007/s40266-022-00983-6). Drugs and Aging, 40(1), 89.
DOI |
| 2023 |
Dorj, G., Nair, N. P., Bereznicki, L., Thu Kelly, L., Pratt, N., Kalisch Ellet, L., . . . Roughead, E. (2023). Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial. Drugs & Aging, 40(1), 49-58.
DOI Scopus7 WoS8 Europe PMC5 |
| 2023 |
Halimi, S. N., Mirzaei, A., Rowett, D., Whitfield, K., & Luetsch, K. (2023). Resilience and empathy in pharmacy interns: insights from a three-year cohort study. Exploratory Research in Clinical and Social Pharmacy, 12(100333), 1-8.
DOI |
| 2023 |
Halimi, S. N., Rowett, D., Whitfield, K., & Luetsch, K. (2023). How early career pharmacists understand resilience - a qualitative study of experiences, challenges and strategies. Research in Social and Administrative Pharmacy, 19(3), 486-494.
DOI |
| 2023 |
Lim, R., Bilton, R., Dorj, G., Bereznicki, L., Rowett, D., Ho, J. N., . . . Roughead, E. E. (2023). Pharmacists as patient advocates: a series of case studies illustrating the impacts of a regular pharmacist service in residential aged care (nursing homes). Exploratory research in clinical and social pharmacy, 10(100268), 1-5.
DOI |
| 2022 |
Hussein, A., Digges, M., Chang, S., Hunt, J., Doogue, M., Rowett, D., . . . Currow, D. C. (2022). Pharmacovigilance in hospice/palliative care: net effect of amitriptyline or nortriptyline on neuropathic pain: UTS/IMPACCT Rapid programme international consecutive cohort. Palliative Medicine, 36(6), 938-944.
DOI Scopus4 Europe PMC3 |
| 2022 |
Lalor, A. F., Brooker, J. E., Rozbroj, T., Whittle, S. L., Hill, C. L., Rowett, D., . . . O'Connor, D. A. (2022). Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies. Seminars in Arthritis and Rheumatism, 55(151988), 151988-1-151988-13.
DOI Scopus5 WoS6 Europe PMC5 |
| 2022 |
Roughead, E. E., Pratt, N. L., Parfitt, G., Rowett, D., Kalisch-Ellett, L. M., Bereznicki, L., . . . Lim, R. (2022). Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial). AGE AND AGEING, 51(4), 1-9.
DOI Scopus24 WoS21 Europe PMC25 |
| 2022 |
Quinlivan, A., Lester, S., Barrett, C., Whittle, S., Rowett, D., Black, R., . . . Hill, C. (2022). Attitudes of Australians with inflammatory arthritis to biologic therapy and biosimilars. Rheumatology Advances in Practice, 6(3), rkac099-1-rkac099-7.
DOI Scopus6 WoS6 Europe PMC6 |
| 2022 |
Khoo, T., Sidhu, N., Marine, F., Lester, S., Quinlivan, A., Rowett, D., . . . Hill, C. L. (2022). Perceptions towards biologic and biosimilar therapy of patients with rheumatic and gastroenterological conditions. BMC Rheumatology, 6(1, article no. 79), 1-10.
DOI Scopus8 WoS6 Europe PMC4 |
| 2021 |
Hill, C. L., Rowett, D., & Dartnell, J. (2021). Improving the quality use of highly specialised drugs. Australian Prescriber, 44(5), 144-145.
DOI |
| 2021 |
Venter, G., Tieu, J., Black, R., Lester, S., Leonardo, N., Whittle, S. L., . . . Hill, C. L. (2021). PERSPECTIVES OF GLUCOCORTICOID USE IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS. ACR Open Rheumatology, 3(4), 231-238.
DOI Scopus13 WoS15 Europe PMC11 |
| 2021 |
Daniels, B., Luckett, T., Holliday, S., Liauw, W., Lovell, M., Phillips, J., . . . Pearson, S. A. (2021). Patterns of oxycodone controlled release use in older people with cancer following public subsidy of oxycodone/naloxone formulations: an Australian population-based study. Asia-Pacific Journal of Clinical Oncology, 17(1), 68-78.
DOI |
| 2021 |
Luetsch, K., Rowett, D., & Twigg, M. J. (2021). A realist synthesis of pharmacist-conducted medication reviews in primary care after leaving hospital: what works for whom and why?. BMJ Quality and Safety, 30(5), 418-433.
DOI |
| 2021 |
Hosie, A., Agar, M., Caplan, G. A., Draper, B., Hedger, S., Rowett, D., . . . Currow, D. C. (2021). Clinicians' delirium treatment practice, practice change, and influences: A national online survey. Palliative Medicine, 35(8), 1553-1563.
DOI |
| 2021 |
Luetsch, K., Maidment, I., Twigg, M., & Rowett, D. (2021). Realist research to inform pharmacy practice and policy. Research in Social and Administrative Pharmacy, 17(12), 2075-2081.
DOI |
| 2021 |
Butcher, B., Hutchings, E., Fazekas, B., Clark, K., Rowett, D., & Currow, D. (2021). Opioid-sparing effects of ketorolac in palliative care patients receiving opioids for chronic cancer-related pain: a systematic literature review. Palliative Medicine, 36(1), 71-80.
DOI |
| 2020 |
Coombes, J. A., Rowett, D., Whitty, J. A., & Cottrell, N. W. (2020). Using a structured, patient-centred, educational exchange to facilitate a shared conversation about stroke prevention medications. Journal of evaluation in clinical practice, 26(2), 635-644.
DOI |
| 2020 |
Hughes, G. A., Rowett, D., Corlis, M., & Sluggett, J. K. (2020). Reducing harm from potentially inappropriate medicines use in long-term care facilities: We must take a proactive approach. Research in Social and Administrative Pharmacy, 17(5), 829-831.
DOI |
| 2020 |
Luetsch, K., Twigg, M., Rowett, D., & Wong, G. (2020). In search for gold - The relevance of realist reviews and evaluations to pharmacy research and policy development. Research in social and administrative pharmacy, 16(6), 836-839.
DOI |
| 2020 |
To, T. H. M., Collier, A., Agar, M. R., Rowett, D., & Currow, D. C. (2020). Symptomatic events in a community palliative care population: a prospective pilot study. Journal of Palliative Medicine, 23(9), 1223-1226.
DOI |
| 2020 |
Heneka, N., Bhattarai, P., Shaw, T., Rowett, D., Lapkin, S., & Phillips, J. L. (2020). Mitigating opioid errors in inpatient palliative care: a qualitative study. Collegian, 27(3), 304-312.
DOI |
| 2020 |
Luckett, T., Newton John, T., Phillips, J., Holliday, S., Giannitrapani, K., Powell Davies, G., . . . Lorenz, K. (2020). Risk of opioid misuse in people with cancer and pain and related clinical considerations: a qualitative study of the perspectives of Australian general practitioners. BMJ open, 10(2, article no. e034363), 1-11.
DOI |
| 2020 |
Clark, K., Byrne, P. G., Hunt, J., Brown, L., Rowett, D., Watts, G., . . . Currow, D. C. (2020). Pharmacovigilance in hospice/palliative care: de-prescribing combination controlled release oxycodone-naloxone. Journal of Palliative Medicine, 23(5), 656-661.
DOI |
| 2020 |
Gallagher, C., Wong, C. X., Hendriks, J. M., Nyfort-Hansen, K., Rowett, D., Bednarz, J., . . . Sanders, P. (2020). Opportunities to reduce the risk of stroke in AF: the REVIEW AF study. European Heart Journal, 41(Supplement_2), 3427.
DOI |
| 2020 |
Frith, P., Sladek, R., Woodman, R., Effing, T., Bradley, S., van Asten, S., . . . Phillips, P. A. (2020). Pragmatic randomised controlled trial of a personalised intervention for carers of people requiring home oxygen therapy. Chronic Respiratory Disease, 17, 1-11.
DOI Scopus2 WoS1 Europe PMC3 |
| 2020 |
Gallagher, C., Nyfort-Hansen, K., Rowett, D., Wong, C. X., Middeldorp, M. E., Mahajan, R., . . . Hendriks, J. M. (2020). Polypharmacy and health outcomes in atrial fibrillation: a systematic review and meta-analysis. Open Heart, 7(1), 9 pages.
DOI Scopus50 WoS45 Europe PMC40 |
| 2020 |
Lim, R., Bereznicki, L., Corlis, M., Kalisch Ellett, L. M., Kang, A. C., Merlin, T., . . . Roughead, E. E. (2020). Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome.. BMJ Open, 10(4), e032851.
DOI Scopus12 WoS12 Europe PMC11 |
| 2020 |
Leonardo, N., Lester, S., Graham, M., Barett, C., Whittle, S., Rowett, D., . . . Hill, C. L. (2020). Selection and perception of methotrexate treatment information in people with rheumatoid arthritis. International Journal of Rheumatic Diseases, 23(6), 805-812.
DOI Scopus22 WoS21 Europe PMC18 |
| 2019 |
Hendriks, J. M., Brooks, A. G., Rowett, D., Moss, J. R., Gallagher, C., Nyfort-Hansen, K., . . . Sanders, P. (2019). Home-based education and learning program for atrial fibrillation: rationale and design of the HELP-AF study. Canadian Journal of Cardiology, 35(7), 846-854.
DOI Scopus18 WoS18 Europe PMC14 |
| 2019 |
Gallagher, C., Rowett, D., Nyfort-Hansen, K., Simmons, S., Brooks, A. G., Moss, J. R., . . . Sanders, P. (2019). Patient-centered educational resources for atrial fibrillation. JACC: Clinical Electrophysiology, 5(10), 1101-1114.
DOI Scopus21 WoS20 Europe PMC16 |
| 2019 |
McCaffrey, N., Flint, T., Kaambwa, B., Fazekas, B., Rowett, D., Currow, D. C., . . . Eckermann, S. (2019). Economic evaluation of the randomised, double-blind, placebo-controlled study of subcutaneous ketamine in the management of chronic cancer pain.. Palliative medicine, 33(1), 74-81.
DOI Scopus3 WoS1 Europe PMC3 |
| 2019 |
Heneka, N., Bhattarai, P., Shaw, T., Rowett, D., Lapkin, S., & Phillips, J. L. (2019). Clinicians' perceptions of opioid error-contributing factors in inpatient palliative care services: a qualitative study. Palliative medicine, 33(4), 430-444.
DOI |
| 2018 |
Heneka, N., Shaw, T., Rowett, D., Lapkin, S., & Phillips, J. L. (2018). Opioid errors in inpatient palliative care services: a retrospective review. BMJ Supportive & Palliative Care, 8(2), 175-179.
DOI |
| 2018 |
Heneka, N., Shaw, T., Rowett, D., Lapkin, S., & Phillips, J. L. (2018). Exploring factors contributing to medication errors with opioids in Australian specialist palliative care inpatient services: a multi-incident analysis. Journal of palliative medicine, 21(6), 825-835.
DOI |
| 2018 |
Coombes, J. A., Rowett, D., Whitty, J. A., & Cottrell, W. N. (2018). Use of a patient-centred educational exchange (PCEE) to improve patient's self-management of medicines after a stroke: a randomised controlled trial study protocol. BMJ open, 8(8, article no. e022225), 1-9.
DOI |
| 2018 |
Westaway, K., Frank, O., Shute, R., Moffat, A., LeBlanc, V., Rowett, D., . . . Roughead, E. (2018). Gathering tips from carers to support people with dementia: an adaptation of the TOP 5 program for community use. International Journal of Evidence-Based Healthcare, 16(2), 128-135.
DOI Scopus2 WoS2 Europe PMC2 |
| 2018 |
Frank, O., & Rowett, D. (2018). Facilitating respectful interprofessional communication: how do we get there?. Journal of pharmacy practice and research, 48(4), 303-305.
DOI |
| 2017 |
To, T. H. M., LeBlanc, T. W., Eastman, P., Neoh, K., Agar, M. R., To, L. B., . . . Currow, D. C. (2017). The Prospective Evaluation of the Net Effect of Red Blood Cell Transfusions in Routine Provision of Palliative Care. Journal of Palliative Medicine, 20(10), 1152-1157.
DOI Scopus36 WoS33 Europe PMC27 |
| 2017 |
Agar, M. R., Lawlor, P. G., Quinn, S., Draper, B., Caplan, G. A., Rowett, D., . . . Currow, D. C. (2017). Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial. JAMA Internal Medicine, 177(1), 34-42.
DOI Scopus302 WoS247 Europe PMC182 |
| 2017 |
Rowett, D. (2017). Fred J Boyd Award 2016: oration. Journal of pharmacy practice and research, 47(2), 163-165.
DOI |
| 2017 |
Galbraith, K., Coombes, I., Matthews, A., Rowett, D., Bader, L. R., & Bates, I. (2017). Advanced pharmacy practice: aligning national action with global targets. Journal of pharmacy practice and research, 47(2), 131-135.
DOI |
| 2016 |
Luetsch, K., Rowett, D., & Punchard, H. (2016). The sweet spot for pharmacy. Journal of pharmacy practice and research, 46(2), 107-111.
DOI |
| 2016 |
Rowett, D. (2016). Looking to the horizon. Journal of pharmacy practice and research, 46(4), 308-309.
DOI |
| 2016 |
Heneka, N., Shaw, T., Rowett, D., & Phillips, J. L. (2016). Quantifying the burden of opioid medication errors in adult oncology and palliative care settings: a systematic review. Palliative medicine, 30(6), 520-532.
DOI |
| 2016 |
Sanderson, C., Quinn, S. J., Agar, M., Chye, R., Clark, K., Doogue, M., . . . Currow, D. C. (2016). Pharmacovigilance in hospice/palliative care: net effect of pregabalin for neuropathic pain. BMJ supportive and palliative care, 6(3), 323-330.
DOI |
| 2016 |
Luetsch, K., & Rowett, D. (2016). Developing interprofessional communication skills for pharmacists to improve their ability to collaborate with other professions. Journal of interprofessional care, 30(4), 458-465.
DOI |
| 2016 |
McCaffrey, N., Hardy, J., Fazekas, B., Agar, M., Devilee, L., Rowett, D., & Currow, D. (2016). Potential economic impact on hospitalisations of the Palliative Care Clinical Studies Collaborative (PaCCSC) ketamine randomised controlled trial. Australian health review, 40(1), 100-105.
DOI Scopus9 WoS8 Europe PMC4 |
| 2015 |
Westaway, K., Frank, O., Husband, A., McClure, A., Shute, R., Edwards, S., . . . Rowett, D. (2015). Medicines can affect thermoregulation and accentuate the risk of dehydration and heat-related illness during hot weather. Journal of clinical pharmacy and therapeutics, 40(4), 363-367.
DOI Scopus112 WoS95 Europe PMC79 |
| 2015 |
Sanderson, C., Quinn, S. J., Agar, M., Chye, R., Clark, K., Doogue, M. P., . . . Currow, D. C. (2015). Pharmacovigilance in hospice/palliative care: net effect of gabapentin for neuropathic pain. BMJ supportive and palliative care, 5(3), 273-280.
DOI |
| 2015 |
Anderson, K., Freeman, C., Rowett, D., Burrows, J., Scott, I., & Rigby, D. (2015). Polypharmacy, deprescribing and shared decision-making in primary care: the role of the accredited pharmacist. Journal of pharmacy practice and research, 45(4), 446-449.
DOI |
| 2015 |
Jackson, S., Martin, G., Bergin, J., Clark, B., Halstead, P., Rowett, D., . . . Sorimachi, K. (2015). Advanced practice: a survey of current perspectives of Australian pharmacists. Journal of pharmacy practice and research, 45(2), 186-192.
DOI |
| 2015 |
Morgan, N. A., Rowett, D., & Currow, D. C. (2015). Analysis of drug interactions at the end of life. BMJ supportive and palliative care, 5(3), 281-286.
DOI |
| 2015 |
Luetsch, K., & Rowett, D. (2015). Interprofessional communication training: benefits to practicing pharmacists. International journal of clinical pharmacy, 37(5), 857-864.
DOI |
| 2015 |
Collier, A., Rowett, D., Allcroft, P., Greene, A., & Currow, D. C. (2015). Academic detailing of general practitioners by a respiratory physician for diagnosis and management of refractory breathlessness: a randomised pilot study. BMC health services research, 15(1, article no. 193), 1-5.
DOI |
| 2014 |
Russell, B. J., Rowett, D., Abernethy, A. P., & Currow, D. C. (2014). Prescribing for comorbid disease in a palliative population: focus on the use of lipid-lowering medications. Internal medicine journal, 44(2), 177-184.
DOI |
| 2014 |
Swetenham, K., Rowett, D., & Stephenson, D. (2014). Clinical networks influencing policy and practice: the establishment of advanced practice pharmacist roles for specialist palliative care services in South Australia. Australian health review, 38(2), 238-241.
DOI |
| 2014 |
Rowett, D., & Currow, D. (2014). Prescribing at the end of life, pharmacovigilance and clinical trials. Internal medicine journal, 23(S2), 6.
DOI |
| 2014 |
Rowett, D., & Currow, D. (2014). Pharmacovigilance in palliative care. Australian prescriber, 37(6), 204-208.
DOI |
| 2014 |
Russell, B. J., Rowett, D., & Currow, D. C. (2014). Pro re nata prescribing in a population receiving palliative care: a prospective consecutive case note review. Journal of the American Geriatrics Society, 62(9), 1736-1740.
DOI |
| 2014 |
Westaway, K. P., Alderman, C. P., Frank, O. R., Husband, A. J., Rowett, D., & Le Blanc, T. (2014). Optimising therapy for patients with neuropathic pain. Journal of Pharmacy Practice and Research, 44(1), 44-47.
DOI Scopus1 |
| 2014 |
Westaway, K., Frank, O., Husband, A., Rowet, D., Rossi, S., Blanc, T., & Shute, R. (2014). Safe use of statins in elderly people. Journal of Pharmacy Practice and Research, 44(3), 138-142.
DOI Scopus4 |
| 2014 |
Kalisch Ellett, L. M., Pratt, N. L., Barratt, J. D., Rowett, D., & Roughead, E. E. (2014). Risk of medication-associated initiation of oxybutynin in elderly men and women. Journal of the American Geriatrics Society, 62(4), 690-695.
DOI Scopus22 WoS20 Europe PMC16 |
| 2013 |
Tait, P. A., Gray, J., Hakendorf, P., Morris, B., Currow, D. C., & Rowett, D. S. (2013). Community pharmacists: a forgotten resource for palliative care. BMJ supportive and palliative care, 3(4), 436-443.
DOI Europe PMC15 |
| 2013 |
Hardy, J., Quinn, S., Fazekas, B., Eckermann, S., Agar, M. R., Spruyt, O., . . . Currow, D. (2013). Reply to K. Jackson et al and W. Leppert. Journal of clinical oncology, 31(10), 1375-1376.
DOI WoS4 Europe PMC4 |
| 2013 |
Abernethy, A., Currow, D., Shelby-James, T., Rowett, D., May, F., Samsa, G., . . . Phillips, P. (2013). Delivery strategies to optimize resource utilization and performance status for patients with advanced life-limiting illness: results from the "palliative care trial" [ISRCTN 81117481]. Journal of Pain and Symptom Management, 45(3), 488-505.
DOI Scopus78 WoS75 Europe PMC57 |
| 2013 |
Crawford, G., Agar, M., Quinn, S., Phillips, J., Litster, C., Michael, N., . . . Currow, D. (2013). Pharmacovigilance in hospice/palliative care: net effect of haloperidol for delirium. Journal of Palliative Medicine, 16(11), 1335-1341.
DOI Scopus39 WoS38 Europe PMC29 |
| 2013 |
Bell, J., Blacker, N., LeBlanc, V., Alderman, C., Phillips, A., Rowett, D., . . . Husband, A. (2013). Prescribing for older people with chronic renal impairment. Australian Family Physician, 42(1), 24-28.
Scopus26 WoS24 Europe PMC18 |
| 2013 |
Bell, J. S., Blacker, N., LeBlanc, V. T., Alderman, C. P., Phillips, A., Rowett, D., . . . Husband, A. (2013). Prescribing for older people with chronic renal impairment. Australian family physician, 42(1), 24-28. |
| 2013 |
Clark, K., Rowett, D., Robinson, M., & Currow, D. C. (2013). Uptake of methylnaltrexone in Australian patients with opioid-induced constipation: a review of the number of prescriptions presented in the first 12 months of subsidisation. BMJ supportive & palliative care, 3(1), 98-102.
DOI |
| 2013 |
To, T. H. M., Agar, M., Shelby James, T., Abernethy, A. P., Doogue, M., Rowett, D., . . . Currow, D. C. (2013). Off-label prescribing in palliative care - a cross-sectional national survey of Palliative Medicine doctors. Palliative medicine, 27(4), 320-328.
DOI |
| 2013 |
Wiseman, R., Rowett, D., Allcroft, P., Abernethy, A., & Currow, D. C. (2013). Chronic refractory dyspnoea: evidence based management. Australian family physician, 42(3), 137-140. |
| 2012 |
Currow, D. C., Vella Brincat, J., Fazekas, B., Clark, K., Doogue, M., & Rowett, D. (2012). Pharmacovigilance in hospice/palliative care: rapid report of net clinical effect of metoclopramide. Journal of palliative medicine, 15(10), 1071-1075.
DOI |
| 2012 |
Currow, D. C., Rowett, D., Doogue, M., To, T. H. M., & Abernethy, A. P. (2012). An international initiative to create a collaborative for pharmacovigilance in hospice and palliative care clinical practice. Journal of palliative medicine, 15(3), 282-286.
DOI |
| 2012 |
Bell, J. S., Blacker, N., Edwards, S., Frank, O., Alderman, C. P., Karan, L., . . . Rowett, D. (2012). Osteoporosis - pharmacological prevention and management in older people. Australian family physician, 41(3), 110-118. |
| 2012 |
Bell, J. S., Mezrani, C., Blacker, N., Le Blanc, V. T., Frank, O., Alderman, C. P., . . . Shute, R. (2012). Anticholinergic and sedative medicines: prescribing considerations for people with dementia. Australian family physician, 41(1-2), 45-49. |
| 2012 |
Bell, J., Blacker, N., Edwards, S., Frank, O., Alderman, C., Karan, L., . . . Rowett, D. (2012). Osteoporosis pharmacological prevention and management in older people. Australian Family Physician, 41(0003), 110-+.
Scopus10 WoS8 Europe PMC3 |
| 2012 |
Bell, J., Mezrani, C., Blacker, N., Tammy, L., Frank, O., Alderman, C., . . . Shute, R. (2012). Anticholinergic and sedative medicines Prescribing considerations for people with dementia. Australian Family Physician, 41(1-2), 45-49.
DOI Scopus53 WoS49 Europe PMC43 |
| 2012 |
Rowett, D. S., Clark, K., Robinson, M. K., & Currow, D. C. (2012). Subsidised use of methylnaltrexone in Australia for palliative care. The medical journal of Australia, 197(9), 492.
DOI WoS1 Europe PMC1 |
| 2012 |
Hardy, J., Quinn, S., Fazekas, B., Plummer, J., Eckermann, S., Agar, M., . . . Currow, D. C. (2012). Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. Journal of clinical oncology, 30(29), 3611-3617.
DOI WoS172 Europe PMC126 |
| 2011 |
Sladek, R. M., Jones, T., Phillips, P., Luszcz, M., Rowett, D., Eckermann, S., . . . Frith, P. (2011). Health, economic, psychological and social impact of educating carers of patients with advanced pulmonary disease (protocol). Contemporary clinical trials, 32(5), 717-723.
DOI Scopus4 WoS4 Europe PMC3 |
| 2011 |
Currow, D. C., Agar, M. R., To, T. H. M., Rowett, D., Greene, A., & Abernethy, A. P. (2011). Adverse events in hospice and palliative care: a pilot study to determine feasibility of collection and baseline rates. Journal of palliative medicine, 14(3), 309-314.
DOI |
| 2011 |
Kerr, S. J., Rowett, D. S., Sayer, G. P., Whicker, S. D., Saltman, D. C., & Mant, A. (2011). All-cause mortality of elderly Australian veterans using COX-2 selective or non-selective NSAIDs: a longitudinal study. British journal of clinical pharmacology, 71(6), 936-942.
DOI |
| 2011 |
Nikles, J., Mitchell, G. K., Schluter, P., Good, P., Hardy, J., Rowett, D., . . . Currow, D. (2011). Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: the case of palliative care. Journal of clinical epidemiology, 64(5), 471-480.
DOI |
| 2010 |
Currow, D. C., Shelby James, T. M., Agar, M., Plummer, J., Rowett, D., Glare, P., . . . Hardy, J. (2010). Planning phase III multi-site clinical trials in palliative care: The role of consecutive cohort audits to identify potential participant populations. Supportive care in cancer, 18(12), 1571-1579.
DOI |
| 2009 |
Rowett, D., Ravenscroft, P. J., Hardy, J., & Currow, D. C. (2009). Using national health policies to improve access to palliative care medications in the community. Journal of pain and symptom management, 37(3), 395-402.
DOI |
| 2009 |
May, F., Simpson, D., Hart, L., Rowett, D., & Perrier, D. (2009). Experience with academic detailing services for quality improvement in primary care practice. Quality and safety in health care, 18(3), 225-231.
DOI |
| 2009 |
Robinson, M., Rowett, D., Leverton, A., & Mabbott, V. (2009). Changes in utilisation of anticholinergic drugs after initiation of cholinesterase inhibitors. Pharmacoepidemiology and drug safety, 18(8), 659-664.
DOI |
| 2009 |
Nikles, J., Mitchell, G., Walters, J., Hardy, J., Good, P., Rowett, D., . . . Currow, D. C. (2009). Prioritising drugs for single patient (n-of-1) trials in palliative care. Palliative medicine, 23(7), 623-634.
DOI |
| 2009 |
Currow, D. C., & Rowett, D. S. (2009). Cancer pain: progress and ongoing issues in Australia. Pain research and management, 14(5), 351-352. |
| 2009 |
Crotty, M., Prendergast, J., Battersby, M., Rowett, D., Graves, S., Leach, G., & Giles, L. (2009). Self-management and peer support among people with arthritis on a hospital joint replacement waiting list: A randomised controlled trial. Osteoarthritis and Cartilage, 17(11), 1428-1433.
DOI Scopus59 WoS53 Europe PMC49 |
| 2008 |
Jackowski, L., Stocks, N., & Rowett, D. (2008). Reducing the risk of adverse thrombotic events - The role of aspirin and clopidogrel. Australian Family Physician, 37(9), 721-726.
Scopus3 WoS1 Europe PMC2 |
| 2008 |
Jackowski, L., Crockett, J., & Rowett, D. (2008). Lipid lowering therapy for adults with diabetes. Australian family physician, 37(1-2), 39-41.
Scopus1 Europe PMC2 |
| 2008 |
Jackowski, L., Crockett, J., & Rowett, D. (2008). Adults with diabetes: pharmacological management of hypertension. Australian family physician, 37(6), 419-421. |
| 2007 |
Broadhurst, N., Barton, C., Rowett, D., Yelland, L., Matin, D., Gialamas, A., & Beilby, J. (2007). A before and after study of the impact of academic detailing on the use of diagnostic imaging for shoulder complaints in general practice. BMC Family Practice, 8(1), WWW 1-WWW 8.
DOI Scopus16 WoS14 Europe PMC12 |
| 2006 |
Abernethy, A., Curnow, D., Hunt, R., Williams, H., Roder-Allen, G., Rowett, D., . . . Phillips, P. (2006). A pragmatic 2x2x2 factorial cluster randomized controlled trial of educational outreach visiting and case conferencing in palliative care - methodology of the Palliative Care Trial [ISRCTN 81117481]. Contemporary Clinical Trials, 27(1), 83-100.
DOI Scopus53 WoS44 Europe PMC41 |
| 2005 |
Stone, C. A., May, F. W., Pinnock, C. B., Elwood, M., & Rowett, D. S. (2005). Prostate cancer, the PSA test and academic detailing in Australian general practice: An economic evaluation. Australian and New Zealand Journal of Public Health, 29(4), 349-357.
DOI Scopus8 Europe PMC4 |
| 2004 |
Crotty, M., Rowett, D., Spurling, L., Giles, L., & Phillips, P. (2004). Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. The American Journal of Geriatric Pharmacotherapy, 2(4), 257-264.
DOI Scopus246 Europe PMC192 |
| 2004 |
Crotty, M., Halbert, J., Rowett, D., Giles, L., Birks, R., Williams, H., & Whitehead, C. (2004). An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age and Ageing, 33(6), 612-617.
DOI Scopus177 WoS159 Europe PMC132 |
| 2004 |
Crotty, M., Whitehead, C., Rowett, D., Halbert, J., Weller, D., Finucane, P., & Esterman, A. J. (2004). An outreach intervention to implement evidence based practice in residential care. BMC Health Services Research, 4(1), 1-6.
DOI Scopus63 WoS59 Europe PMC55 |
| 2003 |
Weller, D., Rowett, D., Esterman, A. J., Pinnock, C., Nicholson, S., Doust, J., & Silagy, C. (2003). Promoting better use of the PSA test in general practice: randomized controlled trial of educational strategies based on outreach visits and mailout. Family Practice, 20(6), 655-661.
DOI Scopus17 WoS17 Europe PMC13 |
| 1999 |
May, F. W., Rowett, D. S., Gilbert, A. L., McNeece, J. I., & Hurley, E. (1999). Outcomes of an educational-outreach service for community medical practitioners: non-steroidal anti-inflammatory drugs. MEDICAL JOURNAL OF AUSTRALIA, 170(10), 471-474.
DOI WoS38 |
| 1996 |
Rowett, D., Latimer, K., Sansom, L., Ruffin, R., May, F., Henderson, G., & Hayball, P. (1996). The effect of hypoxaemia on drug disposition in chronic respiratory failure. European Journal of Clinical Pharmacology, 50(1), 77-82.
DOI Scopus3 WoS2 Europe PMC1 |
